Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Gazette.
Press releases published on September 2, 2025
CorMedix Completes Acquisition of Melinta Therapeutics, Raises Financial Guidance and Announces New Leadership Team
GlobeNewswire
·
September 2, 2025
- Transformational deal for CorMedix that expands and diversifies company’s commercial product portfolio, with seven innovative drug products and a pipeline expansion indication with near-term revenue growth potential - - Revised guidance of pro forma 2025 …
Avicanna LATAM SAS Teams Up With Harrington Wellness to Launch re+PLAY CBD Wellness Brand Topicals in the United States
GlobeNewswire
·
September 2, 2025
re+PLAY is a CBD wellness brand founded by NBA veteran Al Harrington with products utilizing Avicanna’s patented and proprietary CBD formulations. The initial launch of re+PLAY in the United States includes two products available at Harrington Wellness’ …
Zenas BioPharma and Royalty Pharma Enter into Obexelimab Funding Agreement for up to $300 Million
GlobeNewswire
·
September 2, 2025
- Initial $75 million to fund the potential U.S. commercial launch of obexelimab for the treatment of IgG4-Related Disease - - Additional $150 million associated with the upcoming results of the obexelimab Phase 3 INDIGO trial and FDA approval for the …
Maze Therapeutics Appoints Misbah Tahir as Chief Financial Officer
GlobeNewswire
·
September 2, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and metabolic diseases, today …
Neumora Therapeutics to Participate in Upcoming Conferences in September
GlobeNewswire
·
September 2, 2025
WATERTOWN, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven programs that target novel mechanisms of action for a broad range of …
Apollo to Proceed with 5-for-1 Share Consolidation
GlobeNewswire
·
September 2, 2025
VANCOUVER, British Columbia, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Apollo Silver Corp. (“Apollo” or the “Company”) (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF0) is pleased to announce that, further to the Company’s news release dated October 3, 2024, it intends …
Erdene Completes Share Consolidation
GlobeNewswire
·
September 2, 2025
HALIFAX, Nova Scotia, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Erdene Resource Development Corp. (TSX:ERD; MSE:ERDN; OTCQB: ERFCF) ("Erdene" or the "Company") is pleased to announce that further to its news release dated August 25, 2025, the Company has …
Kamada to Participate in Upcoming September Investor Conferences
GlobeNewswire
·
September 2, 2025
REHOVOT, Israel, and HOBOKEN, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the …
NorthWest Announces Drilling Underway at Kwanika
GlobeNewswire
·
September 2, 2025
TORONTO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- NorthWest Copper (“NorthWest” or the “Company”) (TSX-V: NWST) is pleased to announce that drilling is well underway at its 100% owned Kwanika project for the 2025 season. The success of the flow through financing …
Zymeworks Announces Decision to Discontinue Clinical Development of ZW171, a Mesothelin-directed T cell Engager
GlobeNewswire
·
September 2, 2025
VANCOUVER, British Columbia, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to- …
Fortuna to present at Mining Forum Americas 2025 in Colorado Springs, USA
GlobeNewswire
·
September 2, 2025
VANCOUVER, British Columbia, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Fortuna Mining Corp. (NYSE: FSM | TSX: FVI) is pleased to announce that it will be attending Mining Forum Americas, which is being held at the Broadmoor Hotel …
Novaremed Announces Completion of All Patient Visits in NIH-Funded Phase 2b Trial of Non-Opioid Nispomeben for Treating Chronic Pain Associated with Diabetic Peripheral Neuropathy
GlobeNewswire
·
September 2, 2025
Last patient last visit (LPLV) was reached for the 127 adult and elderly patients enrolled into the 12-week placebo-controlled trial with nispomeben (NRD.E1) Topline results are expected in November 2025 The trial builds on Phase 2a double-blind, …
FIRST PATIENT DOSED IN CITRYLL’S PHASE IIA TRIAL EVALUATING CIT-013 IN RHEUMATOID ARTHRITIS
GlobeNewswire
·
September 2, 2025
Randomized multi-center study designed to assess the efficacy, safety, and tolerability of CIT-013 in patients with moderately active rheumatoid arthritis Oss, Netherlands – 2 September 2025 – Citryll, a biotech company pioneering a transformative approach …
Pharming Group appoints Kenneth Lynard as Chief Financial Officer
GlobeNewswire
·
September 2, 2025
Leiden, the Netherlands, September 2, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM; Nasdaq: PHAR) today announced the appointment of Kenneth Lynard as Chief Financial Officer (CFO), effective October 1, 2025. Mr. Lynard is a …